Subcutaneous Recombinant Interferon-β-1a (Rebif®): A Review of its Use in the Treatment of Relapsing Multiple Sclerosis

Author： Sanford Mark   Lyseng-Williamson Katherine A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.14, 2011-10, pp. : 1865-1891

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Subcutaneous Recombinant Interferon- -1a (Rebif®): A Review of its Use in Relapsing-Remitting Multiple Sclerosis

By Murdoch David   Lyseng-Williamson Katherine A.  

Drugs, Vol. 65, Iss. 9, 2005-01 ,pp. : 1295-1312

Adis International

Access to resources Recommend Favorite

Interferon-β-1b: A Review of its Use in Multiple Sclerosis

By Plosker Greg L.  

CNS Drugs, Vol. 25, Iss. 1, 2011-01 ,pp. : 67-88

Adis International

Access to resources Recommend Favorite

Haematological Effects of Interferon-β-1a (Rebif ® ) Therapy in Multiple Sclerosis

By Rieckmann Peter  

Drug Safety, Vol. 27, Iss. 10, 2004-01 ,pp. : 745-756

Adis International

Access to resources Recommend Favorite

Interferon-β1b for the treatment of multiple sclerosis

By Lam Sum   Wang Shan   Gottesman Malcolm  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β1b in the treatment of multiple sclerosis

By Río Jordi   Montalban Xavier  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2877-2886

Informa Healthcare

Access to resources Recommend Favorite